Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9VGT

Crystal structure of Peroxiredoxin I in complex with compound 19-150

This is a non-PDB format compatible entry.
Summary for 9VGT
Entry DOI10.2210/pdb9vgt/pdb
DescriptorPeroxiredoxin-1, methyl (2~{S})-2-[[(2~{R},4~{a}~{S},6~{a}~{S},6~{a}~{R},13~{S},14~{a}~{S},14~{b}~{R})-13-bromanyl-2,4~{a},6~{a},6~{a},9,14~{a}-hexamethyl-10-oxidanyl-11-oxidanylidene-1,3,4,5,6,13,14,14~{b}-octahydropicen-2-yl]carbamoylamino]propanoate (3 entities in total)
Functional Keywordsprdx1, inhibitor, complex, oxidoreductase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight39303.76
Authors
Zhang, H.,Wang, X.M. (deposition date: 2025-06-15, release date: 2026-05-27)
Primary citationLi, M.Y.,Li, Y.,Wang, X.,Shang, F.F.,Long, Y.,Li, Y.L.,Wang, Z.,Zhang, A.,Zhang, H.,Ding, C.,Sun, Z.
Synthesis and pharmacological evaluation of brominated derivatives of natural product celastrol for treatment of hepatic fibrosis.
Eur.J.Med.Chem., 309:118765-118765, 2026
Cited by
PubMed Abstract: Effective therapeutic agents against hepatic fibrosis remain scarce. Natural product Celastrol has demonstrated promising anti-hepatic fibrosis activity. However, further clinical development is impaired by its toxicity. We performed a bromination modification at the C-ring, an unexplored moiety of Celastrol, leading to a series of brominated derivatives. Among them, derivative 5 effectively suppressed various stimulus-induced activation of NLRP3 inflammasome to block the activation of HSCs, thus reducing the collagen deposition. Meanwhile, 5 was identified as a covalent PRDX1 inhibitor with high isoform selectivity, which accelerated ROS accumulation to induce apoptosis of the activated HSCs. Derivative 5 at a dose of 20 mg/kg exhibited superior safety profile with no significant weight loss or hepatotoxicity. At 1 mg/kg, it significantly ameliorates CCl-induced hepatic damage and fibrosis in mice. Taken together, our work provided a novel brominated derivative of Celastrol as promising lead compound against hepatic fibrosis.
PubMed: 41844113
DOI: 10.1016/j.ejmech.2026.118765
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.79 Å)
Structure validation

254917

PDB entries from 2026-06-10

PDB statisticsPDBj update infoContact PDBjnumon